WeVote
Log In

Bill

Bill

HB 326

An Act relating to abortion-inducing drugs.

34th Legislature (2025-2026) Introduced by Kevin McCabe

Alaska HB 326 addresses regulation of abortion-inducing drugs but specific provisions require bill text review to determine restrictions or requirements imposed.

(H) COSPONSOR(S): ST. CLAIR
#abortion #drugs #medicalcare #physicians #women
0
WeVote Research Nonpartisan
Bill Summary · HB 326

Legislative bill overview

HB 326 is an Alaska bill introduced by Representative Kevin McCabe relating to abortion-inducing drugs. The bill has been referred to the House Health & Social Services and Judiciary committees for review. Without access to the bill's specific text, the exact provisions—whether restricting access, regulating dispensing, establishing safety protocols, or other measures—cannot be determined from the available information.

Why is this important

Abortion-inducing medication (primarily mifepristone and misoprostol) represents a significant portion of U.S. abortions and is subject to evolving federal and state regulations. Legislation in this area directly affects reproductive healthcare access, medical practice standards, and implementation of state abortion policy in ways that impact residents' medical options and healthcare providers' operations.

Potential points of contention

  • Whether the bill restricts or expands access to medication abortion, affecting patient choice and healthcare provider authority
  • Regulatory requirements the bill may impose (prescribing protocols, dispensing locations, reporting requirements) and their practical impact on healthcare delivery
  • Alignment or conflict with federal FDA regulations governing these drugs versus state-level control preferences

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.